HIV and Heart Disease: What Cardiologists Should Know

被引：9
作者：
Boccara, Franck [1 ,2 ]
Cohen, Ariel [1 ]
机构：
[1] Paris 06 Univ Pierre & Marie Curie, Sorbonne Univ, Hop St Antoine, AP HP,Serv Cardiol, Paris, France
[2] Univ Paris 06, UMR S 938, INSERM, Paris, France
来源：
REVISTA ESPANOLA DE CARDIOLOGIA | 2016年 / 69卷 / 12期
关键词：
HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; CARDIOVASCULAR-DISEASE; RISK-FACTORS; INFECTION; ASSOCIATION; IMPACT; RATES; MEN;
D O I：
10.1016/j.rec.2016.05.032
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1126 / 1130
页数：5
相关论文
共 21 条
[1]   Cardiovascular manifestations of HIV infection [J].
Barbaro, G .
CIRCULATION, 2002, 106 (11) :1420-1425
[2]   HIV and Coronary Heart Disease Time for a Better Understanding [J].
Boccara, Franck ;
Lang, Sylvie ;
Meuleman, Catherine ;
Ederhy, Stephane ;
Mary-Krause, Murielle ;
Costagliola, Dominique ;
Capeau, Jacqueline ;
Cohen, Ariel .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (05) :511-523
[3]   Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis [J].
Boccara, Franck ;
Mary-Krause, Murielle ;
Teiger, Emmanuel ;
Lang, Sylvie ;
Lim, Pascal ;
Wahbi, Karim ;
Beygui, Farzin ;
Milleron, Olivier ;
Steg, Philippe Gabriel ;
Funck-Brentano, Christian ;
Slama, Michel ;
Girard, Pierre-Marie ;
Costagliola, Dominique ;
Cohen, Ariel .
EUROPEAN HEART JOURNAL, 2011, 32 (01) :41-50
[4]   Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy [J].
D'Ascenzo, Fabrizio ;
Cerrato, Enrico ;
Biondi-Zoccai, Giuseppe ;
Moretti, Claudio ;
Omede, Pierluigi ;
Sciuto, Filippo ;
Bollati, Mario ;
Modena, Maria Grazia ;
Gaita, Fiorenzo ;
Sheiban, Imad .
EUROPEAN HEART JOURNAL, 2012, 33 (07) :875-880
[5]  
Direccion General de Salud Publica Calidad e Innovacion, 2015, VIG EP VIH SIDA ESP
[6]  
Direccion General de Salud Publica Calidad e Innovacion, 2015, MORT VIH SIDA ESP AN
[7]   Disorders of glucose metabolism in patients infected with human immunodeficiency virus [J].
Dubé, MP .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (06) :1467-1475
[8]   Drug Interactions Between Antiplatelet or Novel Oral Anticoagulant Medications and Antiretroviral Medications [J].
Egan, Gregory ;
Hughes, Christine A. ;
Ackman, Margaret L. .
ANNALS OF PHARMACOTHERAPY, 2014, 48 (06) :734-740
[9]  
El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360
[10]   Cardiovascular disease risk factors in HIV patients -: association with antiretroviral therapy.: Results from the DAD study [J].
Friis-Moller, N ;
Weber, R ;
Reiss, P ;
Thiébaut, R ;
Kirk, O ;
Monforte, AD ;
Pradier, C ;
Morfeldt, L ;
Mateu, S ;
Law, M ;
El-Sadr, W ;
De Wit, S ;
Sabin, CA ;
Phillips, AN ;
Lundgren, JD .
AIDS, 2003, 17 (08) :1179-1193
123